Predictive Oncology Inc. (POAI) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is neutral — 1 Hold.
Analysts estimate Earnings Per Share (EPS) of $-31.20 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-2.32 vs est $-31.20 (beat +92.6%). 2025: actual $-13.37 vs est $-1.95 (missed -585.6%). Analyst accuracy: 0%.
POAI Analyst Ratings
Hold
Based on 1 analysts giving stock ratings to Predictive Oncology Inc. in the past 3 months
EPS Estimates — POAI
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$2.32
vs Est –$31.20
▲ 1,244.8% off
2025
Actual –$13.37
vs Est –$1.95
▼ 85.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — POAI
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.002B
vs Est $0.001B
▲ 14.2% off
2025
Actual $0.000B
vs Est $0.009B
▼ 7,349.5% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
